Cart
sales@molnova.com
4-Chloro-4'-hydroxybenzophenone
CAS No. 42019-78-3
4-Chloro-4'-hydroxybenzophenone( —— )
Catalog No. M14432 CAS No. 42019-78-3
4-Chloro-4’-hydroxybenzophenone is an organic compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 28 | In Stock |
|
| 25MG | 37 | In Stock |
|
| 50MG | 60 | In Stock |
|
| 100MG | 80 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 183 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Chloro-4'-hydroxybenzophenone
-
NoteResearch use only, not for human use.
-
Brief Description4-Chloro-4’-hydroxybenzophenone is an organic compound.
-
Description4-Chloro-4’-hydroxybenzophenone is an organic compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number42019-78-3
-
Formula Weight232.66
-
Molecular FormulaC13H9ClO2
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESOC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cox PJ, et al. Acta Crystallogr B. 2008 Apr;64(Pt 2):206-16.
molnova catalog
related products
-
25S-Inokosterone
25S-Inokosterone and 25R-inokosterone exhibit potent inhibition (80-95% at ) against TNF-expression levels in A23187 plus phorbol-myrisrate acetate-induced RBL-2H3 cells, they have excellent anti-atopy activity, thus they could be used to a large range of functional anti-atopy cosmetics.
-
alpha,beta-Dihydroxy...
(-)-alpha,beta-Dihydroxy-N-methyl-N-[(1Z)-2-phenyle thenyl]benzenepropanamide
-
Biotin-(Arg8)-Vasopr...
Biotinyl-(Arg8)-Vasopressin is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
